How do NOAC outcomes compare in AF patients with multiple comorbidities?

Dabigatran, rivaroxaban and warfarin are similarly effective for stroke prevention in patients with atrial fibrillation (AF) and multiple chronic conditions. The findings, from a retrospective US study of Medicare data, extend the evidence for oral anticoagulants in a higher risk group than is typically represented in randomised controlled trials. The study comprised almost 147,000 patients ...

Already a member?

Login to keep reading.

© 2021 the limbic